Britain approves Merck's Covid-19 pill in world first
- 3 years ago
Britain on Thursday became the first country in the world to approve a potentially game-changing Covid-19 antiviral pill jointly developed by US-based Merck & Co Inc and Ridgeback Biotherapeutics, in a boost to the fight against the pandemic.
Britain's Medicines and Healthcare products Regulatory Agency (MHRA) recommended the drug, molnupiravir, for use in people with mild to moderate Covid-19 and at least one risk factor for developing severe illness, such as obesity, older age diabetes, and heart disease.
It will be administered as soon as possible following a positive Covid-19 test and within five days of the onset of symptoms, the regulator said, citing clinical data.
- Reuters -
Britain's Medicines and Healthcare products Regulatory Agency (MHRA) recommended the drug, molnupiravir, for use in people with mild to moderate Covid-19 and at least one risk factor for developing severe illness, such as obesity, older age diabetes, and heart disease.
It will be administered as soon as possible following a positive Covid-19 test and within five days of the onset of symptoms, the regulator said, citing clinical data.
- Reuters -